ImmuPharma plc (IMM.L)
GBp 3.44
(-1.85%)
GBp 3.44
(-1.85%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 GBP | 35.71% |
| 2022 | -0.01 GBP | 61.23% |
| 2021 | -0.03 GBP | 5.25% |
| 2020 | -0.03 GBP | 14.04% |
| 2019 | -0.04 GBP | 23.12% |
| 2018 | -0.05 GBP | -9.26% |
| 2017 | -0.05 GBP | -4.63% |
| 2016 | -0.05 GBP | -3.18% |
| 2015 | -0.04 GBP | -28.28% |
| 2014 | -0.03 GBP | 24.12% |
| 2013 | -0.05 GBP | 4.03% |
| 2012 | -0.05 GBP | -14.6% |
| 2011 | -0.04 GBP | -68.44% |
| 2010 | -0.02 GBP | -124.4% |
| 2009 | 0.10 GBP | 60.51% |
| 2008 | 0.06 GBP | 246.93% |
| 2007 | -0.04 GBP | 0.0% |
| 2005 | -0.04 GBP | -1255.56% |
| 2004 | 0.00 GBP | 1700.0% |
| 2003 | 0.00 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 GBP | 0.0% |
| 2024 Q1 | -0.00 GBP | 81.48% |
| 2023 Q3 | -0.00 GBP | -8.0% |
| 2023 Q1 | -0.00 GBP | 80.6% |
| 2023 FY | - GBP | 35.71% |
| 2023 Q4 | -0.00 GBP | 0.0% |
| 2023 Q2 | -0.00 GBP | -92.31% |
| 2022 Q1 | -0.00 GBP | 83.8% |
| 2022 FY | - GBP | 61.23% |
| 2022 Q2 | -0.01 GBP | -100.0% |
| 2022 Q3 | -0.00 GBP | 41.38% |
| 2022 Q4 | -0.01 GBP | -97.06% |
| 2021 Q1 | -0.01 GBP | 57.8% |
| 2021 Q2 | -0.01 GBP | -100.0% |
| 2021 Q3 | -0.01 GBP | 38.36% |
| 2021 Q4 | -0.02 GBP | -98.89% |
| 2021 FY | - GBP | 5.25% |
| 2020 Q3 | -0.01 GBP | 48.52% |
| 2020 Q2 | -0.02 GBP | -98.82% |
| 2020 FY | - GBP | 14.04% |
| 2020 Q1 | -0.01 GBP | 36.09% |
| 2020 Q4 | -0.02 GBP | -98.85% |
| 2019 Q1 | -0.01 GBP | -23.89% |
| 2019 FY | - GBP | 23.12% |
| 2019 Q3 | -0.01 GBP | 76.43% |
| 2019 Q2 | -0.03 GBP | -100.0% |
| 2019 Q4 | -0.01 GBP | -101.52% |
| 2018 Q2 | -0.01 GBP | 0.0% |
| 2018 Q4 | -0.01 GBP | 0.0% |
| 2018 Q3 | -0.01 GBP | 23.13% |
| 2018 Q1 | -0.01 GBP | -21.49% |
| 2018 FY | - GBP | -9.26% |
| 2017 FY | - GBP | -4.63% |
| 2017 Q4 | -0.01 GBP | 0.0% |
| 2017 Q3 | -0.01 GBP | -3.42% |
| 2017 Q2 | -0.01 GBP | 0.0% |
| 2017 Q1 | -0.01 GBP | -80.0% |
| 2016 Q3 | -0.01 GBP | 61.31% |
| 2016 FY | - GBP | -3.18% |
| 2016 Q2 | -0.02 GBP | 0.0% |
| 2016 Q1 | -0.02 GBP | -26.32% |
| 2016 Q4 | -0.01 GBP | 0.0% |
| 2015 FY | - GBP | -28.28% |
| 2015 Q2 | -0.01 GBP | 0.0% |
| 2015 Q3 | -0.01 GBP | -52.87% |
| 2015 Q4 | -0.01 GBP | 0.0% |
| 2015 Q1 | -0.01 GBP | -42.62% |
| 2014 Q4 | -0.01 GBP | 0.0% |
| 2014 Q2 | -0.01 GBP | 0.89% |
| 2014 Q1 | -0.01 GBP | 4.27% |
| 2014 FY | - GBP | 24.12% |
| 2014 Q3 | -0.01 GBP | 45.05% |
| 2013 Q1 | -0.01 GBP | 14.17% |
| 2013 Q3 | -0.01 GBP | -7.34% |
| 2013 Q4 | -0.01 GBP | 0.0% |
| 2013 FY | - GBP | 4.03% |
| 2013 Q2 | -0.01 GBP | 0.0% |
| 2012 FY | - GBP | -14.6% |
| 2012 Q4 | -0.01 GBP | 0.0% |
| 2012 Q3 | -0.01 GBP | 0.0% |
| 2011 FY | - GBP | -68.44% |
| 2010 FY | - GBP | -124.4% |
| 2009 FY | - GBP | 60.51% |
| 2008 FY | - GBP | 246.93% |
| 2007 FY | - GBP | 0.0% |
| 2006 Q2 | -0.00 GBP | 0.0% |
| 2005 FY | - GBP | -1255.56% |
| 2004 FY | - GBP | 1700.0% |
| 2003 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|